Georgios Karakatsoulis
Georgios Karakatsoulis publishes mostly in Genetics, Oncology and Molecular Biology, on topics such as Chronic Lymphocytic Leukemia Research, Monoclonal and Polyclonal Antibodies Research and Advanced Breast Cancer Therapies.
- World rank
- #1,057,852 of 7,710,434 ranked researchers
- Rank in Greece
- #4,131 of 33,280
- Works
- 56
- Citations
- 379
- Citations per work
- 6.8
What does Georgios Karakatsoulis research?
Georgios Karakatsoulis's work is mostly in Medicine (39%), Biochemistry, Genetics and Molecular Biology (9%), Immunology and Microbiology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else2544.7%
- Health Sciences2239.2%
- Medicine2239.2%
- Life Sciences916.1%
- 1Genetics15% of their works
- 2Oncology11% of their works
- 3Molecular Biology9% of their works
- 4Immunology7% of their works
- 5Radiology, Nuclear Medicine and Imaging7% of their works
- 6Pulmonary and Respiratory Medicine7% of their works
Research topics
- Chronic Lymphocytic Leukemia Research
- Monoclonal and Polyclonal Antibodies Research
- Advanced Breast Cancer Therapies
- Lymphoma Diagnosis and Treatment
- Supply Chain and Inventory Management
- vaccines and immunoinformatics approaches
- Immunodeficiency and Autoimmune Disorders
- Single-cell and spatial transcriptomics
Which keywords describe Georgios Karakatsoulis's research?
The keywords of their largest research topics: Rituximab, Chronic Lymphocytic Leukemia, Genomic Aberrations, Fc Receptors, Therapeutic Antibodies, Breast Cancer, CDK4/6 Inhibitors and Classification.
- Single-Cell
- Peptide-MHC Binding
- Epitope Prediction
- Lymphoma
- Classification
- Breast Cancer
- Fc Receptors
- Chronic Lymphocytic Leukemia
- Rituximab
- Genomic Aberrations
- Therapeutic Antibodies
- CDK4/6 Inhibitors
- Information Sharing
- Supply Chain Coordination
- Genetic Mutations
- Primary Immunodeficiency
- Transcriptomics
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Rituximab242 topics
- Chronic Lymphocytic Leukemia191 topic
- Genomic Aberrations191 topic
- Fc Receptors81 topic
- Therapeutic Antibodies81 topic
- Breast Cancer71 topic
- CDK4/6 Inhibitors71 topic
- Classification51 topic
- Information Sharing51 topic
- Lymphoma51 topic
- Supply Chain Coordination51 topic
- Epitope Prediction41 topic
- Genetic Mutations41 topic
- Peptide-MHC Binding41 topic
- Primary Immunodeficiency41 topic
- Single-Cell31 topic
- Transcriptomics31 topic
Where does Georgios Karakatsoulis work?
Georgios Karakatsoulis's main affiliation in the publication record is Centre for Research and Technology Hellas, Greece.
How many publications and citations does Georgios Karakatsoulis have?
OpenAlex counts 56 works and 379 citations for Georgios Karakatsoulis, an h-index of 9, ranking #1,057,852 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Georgios Karakatsoulis. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.